Eton Pharmaceuticals (ETON) Other Accumulated Expenses (2023 - 2025)

Eton Pharmaceuticals (ETON) has 3 years of Other Accumulated Expenses data on file, last reported at $675000.0 in Q1 2025.

• For the quarter ending Q1 2025, Other Accumulated Expenses changed N/A year-over-year to $675000.0; the trailing twelve-month figure through Mar 2025 stood at $675000.0 (changed N/A YoY), and the FY2023 full-year result was $5.4 million, changed N/A from the prior year.
• Other Accumulated Expenses slipped to $675000.0 in Q1 2025, from $4.9 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $5.4 million in Q4 2023 to a low of $675000.0 in Q1 2025.
• A 3-year average of $3.6 million and a median of $4.9 million in 2024 frame the typical range for Other Accumulated Expenses.